A novel covalent approach to bio-conjugate silver coated single walled carbon nanotubes with antimicrobial peptide by unknown
Chaudhari et al. J Nanobiotechnol  (2016) 14:58 
DOI 10.1186/s12951-016-0211-z
RESEARCH
A novel covalent approach 
to bio-conjugate silver coated single walled 
carbon nanotubes with antimicrobial peptide
Atul A. Chaudhari1, D’andrea Ashmore1, Subrata deb Nath2, Kunal Kate2, Vida Dennis1, Shree R. Singh1, 
Don R. Owen3, Chris Palazzo3, Robert D. Arnold4, Michael E. Miller5 and Shreekumar R. Pillai1*
Abstract 
Background: Due to increasing antibiotic resistance, the use of silver coated single walled carbon nanotubes 
(SWCNTs-Ag) and antimicrobial peptides (APs) is becoming popular due to their antimicrobial properties against a 
wide range of pathogens. However, stability against various conditions and toxicity in human cells are some of the 
major drawbacks of APs and SWCNTs-Ag, respectively. Therefore, we hypothesized that APs-functionalized SWCNTs-
Ag could act synergistically. Various covalent functionalization protocols described previously involve harsh treatment 
of carbon nanotubes for carboxylation (first step in covalent functionalization) and the non-covalently functionalized 
SWCNTs are not satisfactory.
Methods: The present study is the first report wherein SWCNTs-Ag were first carboxylated using Tri sodium citrate 
(TSC) at 37 °C and then subsequently functionalized covalently with an effective antimicrobial peptide from Thera-
peutic Inc., TP359 (FSWCNTs-Ag). SWCNTs-Ag were also non covalently functionalized with TP359 by simple mixing 
(SWCNTs-Ag-M) and both, the FSWCNTs-Ag (covalent) and SWCNTs-Ag-M (non-covalent), were characterized by 
Fourier transform infrared spectroscopy (FT-IR), Ultraviolet visualization (UV–VIS) and transmission electron microscopy 
(TEM). Further the antibacterial activity of both and TP359 were investigated against two gram positive (Staphylococ-
cus aureus and Streptococcus pyogenes) and two gram negative (Salmonella enterica serovar Typhimurium and Escheri-
chia coli) pathogens and the cellular toxicity of TP359 and FSWCNTs-Ag was compared with plain SWCNTs-Ag using 
murine macrophages and lung carcinoma cells.
Results: FT-IR analysis revealed that treatment with TSC successfully resulted in carboxylation of SWCNTs-Ag and 
the peptide was indeed attached to the SWCNTs-Ag evidenced by TEM images. More importantly, the present 
study results further showed that the minimum inhibitory concentration (MIC) of FSWCNTs-Ag were much lower 
(~7.8–3.9 µg/ml with IC50: ~4–5 µg/ml) compared to SWCNTs-Ag-M and plain SWCNTs-Ag (both 62.6 µg/ml, IC50: 
~31–35 µg/ml), suggesting that the covalent conjugation of TP359 with SWCNTs-Ag was very effective on their 
counterparts. Additionally, FSWCNTs-Ag are non-toxic to the eukaryotic cells at their MIC concentrations (5–2.5 µg/ml) 
compared to SWCNTs-Ag (62.5 µg/ml).
Conclusion: In conclusion, we demonstrated that covalent functionalization of SWCNTs-Ag and TP359 exhibited an 
additive antibacterial activity. This study described a novel approach to prepare SWCNT-Ag bio-conjugates without 
loss of antimicrobial activity and reduced toxicity, and this strategy will aid in the development of novel and biologi-
cally important nanomaterials.
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Background
Carbon nanotubes are well known for their wide range of 
applications in diverse fields, including biomedicine [1, 2]. 
Of relevance, single-walled carbon nanotubes (SWNTs) 
have been used for biomedical molecular imaging and 
effective drug delivery in  vivo as well as in  vitro [3–9]. 
Additionally, metallic nanocomposites of SWCNTs, espe-
cially silver coated SWCNTs (SWCNTs-Ag) have shown 
a remarkable antibacterial activity against gram positive 
as well as gram negative pathogens over the past few years 
[10–12]. The results from these studies are promising as 
there is an urgent need of developing novel antimicrobial 
strategies due to increasing resistance to several broad 
spectrum antibiotics [13–15]. However, the application of 
SWCNTs-Ag has been limited due to several known mech-
anisms of toxicity to eukaryotic cells [16–18]. Function-
alization strategies have been developed and reported to 
lessen their toxicity, such as pegylation or surface modifica-
tion using biological entities like DNA/RNA or protein [11, 
12, 16–18]. In our previous study we demonstrated that 
pegylation of SWCNTs-Ag reduced toxicity to different 
eukaryotic cell lines without reducing their anti-bacterial 
activity [11]. Although surface modification of SWCNTs-
Ag reduced their toxic effects on eukaryotic cells, the func-
tionalization was not stable and the dosage required for the 
antibacterial activity remained high (62.5 µg/ml).
Functionalization using antimicrobial peptides (APs) 
may reduce the dosage required for the antibacterial activ-
ity of SWCNTs-Ag due to the antibacterial activity of both 
the components. The application of host derived or syn-
thetic APs are becoming popular due to their effectiveness 
and broad range of antibacterial activity [19–23]. Several 
in  vitro as well as in  vivo models have successfully dem-
onstrated that APs exhibit effective antimicrobial activity 
[23–29]. Despite these advantages, the use of APs has sev-
eral disadvantages, such as enzymatic degradation leading 
to loss of activity, expensive to produce and instability in 
solution. However, a suitable delivery vehicle can mitigate 
these challenges by enhancing delivery of the peptides to 
the infected site and minimizing degradation. Carbon 
nanotubes have been used effectively as a formulation 
platform for the targeted delivery of anticancer agents, 
DNAs, RNAs and proteins [30–35]. Thus, functionali-
zation of SWCNTs to produce nanotube bioconjugates 
for the desired application is a rational approach. In gen-
eral, functionalization can be achieved by either covalent 
bonding or non-covalent interactions to SWCNTs [30, 
31, 33, 34]. However, various covalent functionalization 
protocols involves harsh treatment of carbon nanotubes 
such as oxidation of nanotubes, addition of 1,3-dipolar 
cycloaddition on the nanotube sidewalls or treatment with 
highly concentrated acids such as HNO3 and H2SO4 [33, 
36–38]. Although covalent chemical reactions offer stable 
functionalized SWCNTs, the sidewalls of the nanotubes 
get severely damaged in the process. In contrast, non-
covalent functionalization by amphiphilic molecules either 
through passive absorption or by coating of the nanotube 
surfaces maintains the structure and optical properties of 
SWCNTs [33]. However, non-covalently functionalized 
SWCNTs are of limited use due to poor stability and issues 
associated with biocompatibility. Although, SWCNTs have 
been functionalized earlier using anti-cancer drugs, DNA, 
RNA or proteins [30, 32–35], the metallic nanocomposites 
of SWCNTs such as SWCNTs-Ag have yet to be success-
fully functionalized with biological molecules.
Therefore a unique strategy is required which will 
result in minimal damage to the structure of SWCNTs-
Ag, provide maximum biocompatibility and optimum 
antibacterial activity with high potency (i.e., relatively 
low dosage). In the present study, we developed a novel 
approach to functionalize SWCNTs-Ag covalently using 
an effective antimicrobial peptide from Therapeutic Inc, 
TP359. The functionalized SWCNTs-Ag were further 
characterized by Fourier transform infrared spectroscopy 
(FT-IR) and transmission electron microscopy (TEM) 
and compared with the non-covalently functionalized 
SWCNTs-Ag. Further, the antibacterial activity of func-
tionalized SWCNT-Ag (covalent as well as non-covalent) 
was investigated against two gram positive (Staphylococ-
cus aureus and Streptococcus pyogenes) and two gram 
negative pathogens (Salmonella enterica serovar Typh-
imurium and Escherichia coli).
Results
Carboxylation of silver coated‑single walled carbon 
nanotubes (SWCNTs‑Ag)
Carboxylation on the surface of SWCNTs-Ag was con-
firmed by FT-IR. FT-IR spectrum of pure TSC, SWCNTs-
Ag and different ratios of TSC to SWCNTs-Ag are shown 
in Fig. 1a–f. The characteristic absorption bands of –COO 
at around 1394 (symmetric stretching) and 1589  cm−1 
(asymmetric stretching), and –COOH bands at around 
3322 cm−1 were observed on pure TSC whereas the pure 
SWCNTs-Ag did not show any of these characteristic 
peaks on their surfaces (Fig. 1e, f ). The similar peaks cor-
responding to the –COO and –COOH stretching were 
observed on TSC treated SWCNTs-Ag at different ratios 
(Fig. 1a–d). The presence of –COOH and –COO stretch-
ing on the TSC-SWCNTs-Ag confirmed the carboxyla-
tion of SWCNTs-Ag with the treatment of TSC.
Covalent and non‑covalent functionalization 
of SWCNTs‑Ag with an antimicrobial peptide TP359
Figure 2 shows the FT-IR pattern of the plain SWCNTs-
Ag, TP359, FSWCNTs-Ag (covalent) and SWCNTs-Ag-
M (non-covalent). FSWCNTs-Ag showed presence of 
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functional groups for alcohols and phenols (–O–H) at 
3400–3600  cm−1, carbonyl (–C=O) at 1760  cm−1 and 
amine (N–H) stretches at 1580  cm−1 similar to that of 
TP359, whereas SWCNTs-Ag did not exhibit any of these 
peaks (Fig.  2a–c). Conversely, the non-covalent bond-
ing of SWCNTs-Ag and the peptide (SWCNTs-Ag-M) 
showed the presence of alkane (–C–H) at 3000 cm−1 and 
amine stretch at 1580 cm−1 similar to that of TP359 how-
ever the –O–H stretch was not apparent (Fig.  2d). The 
FT-IR spectra thus showed the non-covalent and cova-
lent functionalization of SWCNTs-Ag with TP359, later 
being more apparent (Fig. 2). Similarly, the UV–VIS pat-
tern of FSWCNTs-Ag, SWCNTs-Ag and SWCNTs-Ag-
M showed a characteristic peak only on FSWCNTs-Ag at 
~250 nm validating the functionalization (Fig. 3).
Further, TEM imaging of SWCNTs-Ag, TSC-SWC-
NTs-Ag, TP359, SWCNTs-Ag-M and FSWCNTs-Ag 
was performed and the electronmicrographs are pre-
sented in Fig.  4a–e. The silver coating on SWCNTs-Ag 
and TSC-SWCNTs-Ag can be visualized clearly (Fig. 4a, 
b, indicated by white dotted arrows) indicating that TSC 
treatment did not alter the silver coating on the SWC-
NTs. TEM images of SWCNTs-Ag-M showed that the 
peptide adhered onto the surface of the SWCNTs-Ag 
resulting in the coating of SWCNTs-Ag surface with 
the peptide (Fig. 4d, indicated by a yellow solid arrow). 
While in the FSWCNTs-Ag samples, the peptide 
appeared to be attached to SWCNTs-Ag (Fig.  4e, indi-
cated by red solid arrow). Similarly, AFM analysis of 
FSWCNTs-Ag and plain SWCNTs-Ag was performed 
to further validate the above findings. Figure  5 shows 
the surface characteristics of plain SWCNTs-Ag and 
FSWCNTs-Ag. SWCNTs-Ag appears to be homogene-
ously distributed on the surface and there was no signifi-
cant elevation observed on their surface (Fig. 5a–d). In 
contrast, peptide attachment appears to be evident on 
FSWCNTs-Ag characterized by significant elevation on 
the surface (Fig. 5e–h).
Fig. 1 FT-IR pattern of carboxylated silver coated single walled carbon nanotubes (SWCNTs-Ag) treated with Tri-sodium citrate (TSC). The FT-IR 
spectra of SWCNTs-Ag treated with TSC using different ratios was investigated for the observation of the characteristic peaks related to carboxyl 
group. a TSC-SWCNTs-Ag (1:20); b TSC-SWCNTs-Ag (1:10); c TSC-SWCNTs-Ag (1:7.5); d TSC-SWCNTs-Ag (1:5); e SWCNTs-Ag; f TSC. The character-
istic peaks on TSC and various TSC treated SWNTs-Ag such as carboxylic group stretches such as –COOH at 3300 cm−1 and –COO at 1300 and 
1700 cm−1
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Antibacterial activity of FSWCNTs‑Ag compared 
to SWCNTs‑Ag‑M, SWCNTs‑Ag, TP359 and TSC‑SWCNTs‑Ag
The MICs of FSWCNTs-AG, SWCNTs-Ag-M, SWC-
NTs-Ag, TP359 and TSC-SWCNTs-Ag were investigated 
against two gram negative and two gram positive bac-
teria. Also the quantitative (cfu/ml) analysis of bacteria 
exposed to these nanocomposites was determines using 
plate counting assay. The MICs of FSWCNTs-AG, SWC-
NTs-Ag-M, SWCNTs-Ag, TP359 and TSC-SWCNTs-Ag 
are shown in Additional file 1: Figure S1. Table 1 repre-
sents the MICs, bactericidal and bacteriostatic concen-
trations. The MICs for TP359 and FSWCNTs-Ag were 
lower compared to SWCNTs-Ag, SWCNTs-Ag-M and 
TSC-SWCNTs-Ag (Additional file 1: Figure S1; Table 1). 
TP359 exhibited strong antibacterial activity against all 
four pathogens and the MIC values were in between 7.8–
3.9  µg/ml (Escherichia coli); 1.9–0.9  µg/ml (Salmonella 
Fig. 2 FT-IR pattern of silver coated single walled carbon nanotubes (SWCNTs-Ag) functionalized with the antimicrobial peptide TP359. SWCNTs-Ag 
were either carboxylated using TSC and subsequently functionalized with TP359 (FSWCNTs-Ag) or simply mixed with TP359 (SWCNTs-Ag-M) and 
FT-IR spectra of both the formulations was investigated. a SWCNTs-Ag; b TP359; c FSWCNTs-Ag; d SWCNTs-Ag-M. The characteristic peaks for amine 
groups (N–H) at 1580–1650 cm−1, alkane group (C–H) at 3100 cm−1, carbonyl group (C=O) at 1760 cm−1 and carboxylic group (O–H) at 3300 cm−1 
was observed on TP359, FSWCNTs-Ag and SWCNTs-Ag-M
Fig. 3 UV–VIS pattern of silver coated single walled carbon nano-
tubes (SWCNTs-Ag) functionalized with the antimicrobial peptide 
TP359. SWCNTs-Ag were functionalized with TP359 (FSWCNTs-Ag) 
or simply mixed with TP359 (SWCNTs-Ag-M) and UV-VIS spectra of 
both the formulations was investigated and compared with the 
plan SWCNTs-Ag and TP359. The characteristic peak at ~250 nm on 
FSWCNTs-Ag 1 was observed on TP359 compared to SWCNTs-Ag and 
SWCNTs-Ag-M
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Typhimurium) and 3.9–1.9  µg/ml (for Staphylococcus 
aureus and Streptococcus pyogenes). On the other hand, 
the MIC for SWCNTs-Ag was in between 62.5–31.3 µg/
ml and 125–62.5  µg/ml against gram −ve (Escheri-
chia coli and Salmonella Typhimurium) and gram +ve 
(Staphylococcus aureus and Streptococcus pyogenes) bac-
teria, respectively (Table 1). Compared to SWCNTs-Ag, 
FSWCNTs-Ag exhibited stronger antibacterial activity at 
much lower concentration such as 7.8–3.9 µg/ml (against 
Escherichia coli, Staphylococcus aureus and Streptococ-
cus pyogenes, TP359 concentration is 0.3  µg/ml) and 
1.9–0.9  µg/ml (Salmonella Typhimurium, TP359 con-
centration is 0.08 µg/ml). On the contrary for SWCNTs-
Ag-M (non-covalent functionalization strategy), the MIC 
values were still greater than FSWCNTs-Ag and TP359 
against Escherichia coli and Salmonella Typhimurium 
(31.3–15.6 µg/ml); Staphylococcus aureus (62.5–31.3 µg/
ml) and Streptococcus pyogenes (125–62.5  µg/ml). MIC 
values of TSC-SWCNTs-Ag against all four bacterial 
pathogens were similar to that of MICs of SWCNTs-Ag 
(Additional file  1: Figure S1; Table  1). Additionally, the 
quantitative analysis of bacteria exposed to these concen-
trations showed logarithmic decrease in all four bacterial 
pathogens (Fig. 6a–d). The half maximal inhibitory con-
centrations (IC50) values (based on the quantitative bac-
terial growth vs concentrations) for FSWCNTs-Ag (range 
for all four 1.3–5 µg/ml) were ~tenfolds lower than plain 
SWCNTs-Ag (range for all four 23–35 µg/ml) (Additional 
file 1: Table S1). Further, the KB assay results, presented 
as Table  2 [(Escherichia coli and Salmonella Typhimu-
rium, Additional file  1: Figure S2) and Additional file  1: 
Figure S3 (Staphylococcus aureus and Streptococcus pyo-
genes)], confirmed the antibacterial activity of FSWC-
NTs-Ag and TP359 compared to SWCNTs-Ag. The zone 
of inhibition for TP359 and FSWCNTs-Ag against E 
coli was observed at 20, 10 and 5  µg/ml concentrations 
whereas SWCNTs-Ag showed slight zone of inhibition 
only at 20 µg/ml (Table 2, Additional file 1: Figure S2a–
c). When Salmonella Typhimurium were treated with 
TP359 and FSWCNTs-Ag at different concentrations, a 
clear zone of inhibition was observed for all the concen-
trations compared to SWCNTs-Ag (Table  2; Additional 
file 1: Figure S2a–c). Similarly, TP359 and FSWCNTs-Ag 
inhibited the growth of gram positive bacteria at 20, 10 
and 5 µg/ml and showed clear zone of inhibition whereas 
SWCNTs-Ag did not show inhibition at any concentra-
tions (Table 2; Additional file 1: Figure S3a–c).  
In vitro cell toxicity of TP359, SWCNTs‑Ag and FSWCNTs‑Ag
Next, we explored the cell toxicity of TP359, FSWC-
NTs-Ag and SWCNTs-Ag at four different concentra-
tions. Figure  7a–f represents cell toxicity of TP359, 
Fig. 4 Transmission electron microscopy of silver coated single walled carbon nanotubes (SWCNTs-Ag) functionalized with the antimicrobial 
peptide TP359. Carboxylated SWCNTs-Ag were functionalized with TP359 and the functionalization of the peptide was confirmed by TEM imaging. 
a SWCNTs-Ag; b TSC-SWCNTs-Ag; c TP359; d SWCNTs-Ag-M; e FSWCNTs-Ag. The attachment of the peptide to the SWCNTs-Ag is seen clearly
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SWCNTs-Ag and FSWCNTs-Ag in A549 (Fig.  7a, c, e) 
and J774 cells (Fig. 7b, d, f ). TP359 was not toxic to A549 
cells or J774 cells at any concentration tested (Fig.  7a, 
b). On the other hand, FSWCNTs-Ag and SWCNTs-Ag 
were significantly toxic at 20 and 10 µg/ml (with approxi-
mately 30  % cell staining) and were relatively non-toxic 
at 5 and 2.5 µg/ml concentrations and almost 90 % cells 
relative to control (Fig. 7c–f).
Discussion
The present study reports a novel strategy for covalent 
attachment of antimicrobial peptide to SWCNTs-Ag 
and antibacterial activity of covalently functionalized 
SWCNTs-Ag compared to non-covalently functionalized 
SWCNTs-Ag. In this approach, SWCNTs-Ag were suc-
cessfully carboxylated using Tri sodium citrate (TSC) and 
did not involve the use of extreme treatments of SWC-
NTs-Ag for carboxylation. TSC is a well-known reduc-
ing agent and have been engaged in the size controlled 
synthesis of gold nanoparticles (GNPs) [39, 40]. Besides 
its role in synthesis of nanoparticles, TSC have also been 
reported to carboxylate nanoparticles such as GNPs and 
superparamagnetic iron oxide nanoparticles [41–43]. 
Congruent with these previous findings, our data showed 
that treatment of SWCNTs-Ag with TSC resulted in car-
boxylation of SWCNTs-Ag. However, the striking dif-
ference between our study and the previously reported 
findings is that we used a range of relatively less con-
centrations of TSC [approximately 0.15 (1:20 ratio) to 
0.60  mM (1:5 ratio)] for carboxylation of SWCNTs-Ag 
compared to 40  mM of TSC that was used to carboxy-
late the gold nanoparticles [43]. As reported previously 
[42, 43], the nanoparticles were treated with TSC at high 
temperatures (90 °C) whereas in this study SWCNTs-Ag 
were treated with TSC at 37 °C. Carboxylation of SWC-
NTs generally involves harsh acidic treatments such as 
combination of H2SO4 and HNO3 at extreme tempera-
tures that has been associated with physical damage to 
Fig. 5 Atomic force microscopy (AFM). Structural characterization of FSWCNTs-Ag and SWCNTs-Ag was carried out to further validate the conjuga-
tion of TP359 to SWCNTs-Ag in FSWCNTs-Ag. a–d AFM analysis of plain SWCNTs-Ag. e–h AFM analysis of FSWCNTs-Ag. SWCNTs-Ag in two (a, b) and 
three (c, d) dimensional views. FSWCNTs-Ag are presented as two (e, f) and three (g, h) dimensional images. The cantilever oscillation frequency 
was tuned to the resonance frequency of approximately 256 kHz. The set point voltage was adjusted for optimum image quality. Both height and 
phase information were recorded at a scan rate of 0.7 Hz, and in 512 × 512 pixel format
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carbon nanotubes [36, 44, 45]. Our results demonstrated 
that SWCNTs-Ag can be carboxylated without exposure 
to extreme temperatures or high concentration of chemi-
cals that are associated with degradation.
Further, the carboxylated SWCNTs-Ag were covalently 
functionalized with the antimicrobial peptide TP359, and 
non-covalent functionalization was achieved by simply 
mixing TP359 and plain SWCNTs-Ag. Non-covalent 
functionalization (SWCNTs-Ag-M) showed adherence of 
the peptide onto the surface of the SWCNTs-Ag whereas 
covalent functionalization (FSWCNTs-Ag) showed the 
attachment of the peptide to SWCNTs-Ag. It has been 
established that covalent functionalization of nanoparti-
cles exhibit greater stability and improved activity [36–
38]. In contrast, non-covalent functionalization is highly 
unstable and less effective than the covalent bonding 
[33]. The protocol described herein provides a relatively 
simple and stable approach to the covalent functionali-
zation of the SWCNTs-Ag that neither involves extreme 
chemical treatment, nor causes damage to the carbon 
nanotubes due to exposure to high temperatures.
Evaluation of antibacterial activity of FSWCNTs-AG, 
SWCNTs-Ag-M, SWCNTs-Ag, TP359 and TSC-SWC-
NTs-Ag revealed that the antibacterial concentrations 
of FSWCNTs-Ag were much lower compared to SWC-
NTs-Ag-M and TSC-SWCNTs-Ag, suggesting that 
the covalent conjugation of TP259 with SWCNTs-Ag 
showed increased efficacy compared to their counter-
parts as far as the antibacterial activity was concerned. 
It is therefore interesting to examine the mechanism of 
antibacterial action of the FSWCNTs-Ag compared to 
the peptide alone and SWCNTs-Ag. The present study 
thus defines a novel protocol to functionalize the silver 
coated single walled carbon nanotubes with the peptide 
which can be used to further evaluate the exact mecha-
nism for antibacterial action for peptide functional-
ized SWCNTs-Ag compared with peptide and plain 
SWCNTs-Ag alone. The functionalization of SWCNTs 
with DNA, RNA or chemotherapeutic drugs has shown 
remarkable success in achieving the desired targets for 
the action of these biological molecules [30, 32–35]. 
However, it is known that the SWCNTs exhibit less 
potent antibacterial activity compared to SWCNTs-Ag 
(MIC concentrations 62.5 µg/ml). Therefore in this study, 
we attempted the functionalization of SWCNTs-Ag (vs. 
un-functionalized SWNCTs) with a known antimicro-
bial peptide in order to reduce the effective antimicro-
bial dosage of SWCNTs-Ag. This may has potential to 
reduce off the toxicity of SWCNTs-Ag to human cells 
and may reduce the emergence of drug resistance phe-
notypes. Our results suggested that covalently conju-
gating the peptide to SWCNTs-Ag effectively reduced 
Table 1 MICs, bactericidal and bacteriostatic concentrations
The p ≤ 0.05 indicating significant * differences, or p ≤ 0.01 indicating highly significant ** differences
Material Concentration (µg/ml)
Escherichia coli Salmonella Typhimurium Staphylococcus aureus Streptococcus pyogenes
TP359
 MICs 7.8–3.9 1.9–0.9 3.9–1.9 3.9–1.9
 Bactericidal 7.8* 1.9* 3.9* 3.9*
 Bacteriostatic 3.9* 0.9* 1.9* 1.9*
SWCNTs-Ag
 MICs 62.5–31.2 62.5–31.2 125–62.5 125–62.5
 Bactericidal 62.5 62.5 125 125
 Bacteriostatic 31.2 31.2 62.5 62.5
TSC-SWCNTs-Ag
 MICs 62.5–31.2 62.5–31.2 125–62.5 125–62.5
 Bactericidal 62.5 62.5 125 125
 Bacteriostatic 31.2 31.2 62.5 62.5
FSWCNTs-Ag
 MICs 7.8–3.9** 1.9–0.9** 7.8–3.9* 7.8–3.9**
 Bactericidal 7.8* 1.9** 7.8** 7.8**
 Bacteriostatic 3.9 0.9 3.9 3.9
SWCNTs-Ag-M
 MICs 31.2–15.6 31.2–15.6 62.5–31.2 125–62.5
 Bactericidal 31.2 31.2 62.5 125
 Bacteriostatic 15.6 15.6 31.2 62.5
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the antibacterial dosage of the SWCNTs-Ag as well as 
TP359. We also demonstrated that noncovalent function-
alization did not show any significant antibacterial activ-
ity compared to SWCNTS-Ag. It should be noted that 
FSWCNTs-Ag and SWCNTs-Ag-M, were washed after 
incubation and resulted in the loss of unbound (in case of 
FSWCNTs-Ag) and non-adherent (in case of SWCNTs-
Ag-M) TP359. The loss of the TP359 in the supernatant 
of SWCNTs-Ag-M was greater than the supernatant of 
FSWCNTs-Ag (Table 3). As expected, this suggests that 
non-covalent binding of the peptide (SWCNTs-Ag-M) 
is relatively unstable and is easily removed in the super-
natant and therefore SWCNTs-Ag-M did not exhibit any 
significant antibacterial activity as good as FSWCNTs-
Ag. Although the supernatant of FSWCNTs-Ag lost most 
(almost 80 %) of the unbound TP359, FSWCNTs-Ag still 
exhibited effective antibacterial properties which indicate 
that the covalent bonding of the peptide to SWCNTs-
Ag is stable. Our results also indicated that treatment of 
SWCNTs-Ag with TSC did not affect the antibacterial 
activity of SWCNTs-Ag. TSC is used widely as a reduc-
ing agent. It is possible that the treatment with TSC may 
reduce the silver coating on the SWCNTs and could 
result into the loss of antibacterial activity. However, 
based on TEM and the antibacterial activity assay we did 
not observe loss of the silver coating on the SWCNTs-
Ag. This may be a result of using lower concentrations of 
TSC for carboxylation of SWCNTs-Ag. The results from 
the present study are interesting as the novel FSWCNTs-
Ag exhibited excellent antibacterial activity. However, it 
is important to further evaluate the antibacterial activity 
in detail using advanced methodology such as scanning 
electron microscopy, transmission electron microscopy, 
qRTPCR studies to evaluate gene expression, haemolytic 
activity etc.
Finally the cytotoxicity of FSWCNTs-AG, SWCNTs-
Ag and TP359 was evaluated. It has been reported that 
non covalent functionalization of SWCNTs or SWCNTs-
Ag using non-toxic polymers such as poly ethylene gly-
col reduces the toxicity in eukaryotic cells [11, 18, 41, 
Fig. 6 Quantitative analysis of gram positive and gram negative bacteria exposed to various concentrations of nanocomposites. a log cfu/ml of 
surviving Escherichia coli upon exposure to peptide and nanocomposites. b Quantification of Salmonella Typhimurium upon exposure to peptide 
and nanocomposites. c Staphylococcus aureus exposed to various nanocomposites. d Quantitative analysis of Streptococcus pyogenes. Bacteria were 
grown in LB broth containing various concentrations of nanocomposites and all the cultures were incubated at 37 °C with shaking at 250 rpm and 
the cfu/ml counts were done at 24 h. Statistical differences were indicates as * when p ≤ 0.05, or ** when value was p ≤ 0.01. Error bars represent 
standard deviations determined from at least four replicates
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44, 45]. In our previous report we have shown success-
fully that non-covalently pegylated SWCNTs-Ag are less 
toxic compared to non-pegylated SWCNTs-Ag at their 
bactericidal concentrations [11]. In the present study 
our results suggest that covalent functionalization with 
peptide did not reduce the toxicity of SWCNTs-Ag, as 
SWCNTS-Ag and FSWCNTs-Ag were toxic at higher 
concentrations (20 and 10  µg/ml) and the toxicity was 
reduced further at lower concentrations (Fig.  7). How-
ever, the important difference between the two formu-
lations is that the FSWCNTs-Ag retained antibacterial 
activity at lower concentrations whereas non-function-
alized SWCNTs-Ag (although being non-toxic at lower 
concentrations) did not exhibit antibacterial activity at 
equal concentrations. In particular, MIC concentrations 
of the FSWCNTs-Ag against Salmonella Typhimurium 
Fig. 7 In vitro cytotoxicity assay for TP359, SWCNTs-Ag and FSWCNTs-Ag. a Cytotoxicity of A549 cells exposed to TP359. b Toxicity to J774 cells 
exposed to various concentrations of TP359. c A549 cell viability exposed to SWCNTs-Ag. d Cell viability of J774 treated with SWCNTs-Ag. e A549 
cells viability treated with FSWCNTsAg. f Toxicity of J774 cells exposed to FSWCNTs-Ag. All cells were treated with the peptide and nanocomposites 
for 24 and 48 h and statistical differences were calculated compared to controls. All values were expressed as fold change expressed compared to 
non-treated bacteria. * when p ≤ 0.05 indicate significant differences; ** when p ≤ 0.01 indicate highly significant differences. Error bars represent 
standard deviations of the results determined with at least three biological replicates
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are much lower than its not-toxic concentrations to 
eukaryotic cells. It is still not clear if the conjugation 
efficiency can be enhanced by increasing the peptide 
concentration or how different conditions, such as pH 
variation, temperature etc., affect the stability of the 
FSWCNTs-Ag; these factors are under investigation.
Conclusions
In conclusion, the present study describes a novel 
approach for covalent bio-conjugation of silver coated 
SWCNTs with an antimicrobial peptide. Functionaliza-
tion exhibited an “additive effect” relationship between 
the SWCNTs-Ag and TP359 as far as antibacterial activ-
ity is concerned. This additive effect is evidenced by the 
requirement of much lower concentrations of the TP359 
(0.3–0.08 µg/ml) and SWCNTs-Ag (7.8–1.9 µg/ml) in the 
FSWCNTs-Ag to obtain the desired antibacterial effect 
against all bacterial pathogens compared to the plain 
TP359 (MIC: 7.8–1.9  µg/ml) and SWCNTs-Ag (MIC: 
125–62.5  µg/ml). Also the IC50 values of FSWCNTs-
Ag (~4–5  µg/ml) were much lower as opposed to plain 
SWCNTs-Ag IC50: ~31–35  µg/ml) More importantly, 
our results showed that the FSWCNTs-Ag are non-toxic 
to murine macrophages and Hep2 cells at their MIC 
concentrations (5–2.5 µg/ml). The protocol described in 
the present study provides a beneficial approach to bio-
conjugate SWCNTs-Ag and will aid into development of 
novel and biologically important nanomaterials.
Methods
Preparation of nanomaterial and antimicrobial peptide 
TP359
Silver (typically 40–50 wt%) coated single walled car-
bon nanotubes (SWCNTs-Ag), were purchased from 
NanoLab, Inc. Waltham, MA, USA. One milligrams of 
SWCNTs-Ag were dispersed in 1  ml of sterile distilled 
water to produce its aqueous dispersion. The dispersion 
was immediately sonicated for 1–2 h to obtain the SWC-
NTs-Ag dispersion (1 mg/ml). Similarly, 1 mg of a novel 
antimicrobial peptide from Therapeutic peptides Inc. 
(Baton Rouge, LA, USA), TP359 of 5 amino acids, was 
solubilized in sterile water. TP359 is a lipidated cationic 
oligopeptide (LCOP), myristoyl-KKALKd amide (US Pat-
ent 8431523).
Carboxylation of SWCNTs‑Ag using tri‑sodium citrate (TSC)
SWCNTs-Ag were carboxylated using Trisodium cit-
rate dihydrate (TSC) (Alfa Aesar, Ward Hill, MA, USA) 
as described previously with fewer modifications [42, 43, 
46]. Briefly, SWCNTs-Ag were mixed with TSC at differ-
ent ratios of TSC to SWCNTs-Ag (1 mg/ml) such as 1:20 
(1 part of TSC to 20 parts of SWCNTs-Ag), 1:10, 1:7.5 
and 1:5. The mixture was subjected to continuous stirring 
at 37  °C for 4  h. The samples were designated as TSC-
SWCNTs-Ag, vacuum dried and the coating of carboxyl 
group on SWCNTs-Ag surface was further analyzed 
using FT-IR as described elsewhere [11].
Bio‑conjugation of TP359 to carboxylated SWCNTs‑Ag 
using covalent bonding
The carboxylated SWCNTs-Ag were covalently conju-
gated with TP359 using a 1-Ethyl-3-(3-dimethylamino-
propyl) carbodiimide (EDC, Sigma Aldrich, St. Louis, 
MO, USA) and N-Hydroxysuccinimide (NHS, Sigma 
Aldrich, St. Louis, MO, USA). Briefly, 1  mg of TSC-
treated SWCNTs-Ag (1:20) were mixed with 0.5  mg of 
EDC and 0.25  mg of NHS and subjected to continuous 
stirring for 1  h, followed by addition of 1  mg of TP359 
and stirring of the mixture for 4 h. Unbound peptide was 
removed by repeated centrifugation (at least four times) 
at 40,000×g for 50 min and the functionalized SWCNTs-
Ag (FSWCNTs-Ag) were finally re-suspended in sterile 
nuclease-free water 1  ml. Each wash after centrifuga-
tion was collected to measure the peptide concentration 
Table 3 TP359 peptide concentration measure by BSA assay
a Silver coated single walled carbon nanotubes (SWCNTs-Ag) were functionalized with TP359 either covalently (FSWCNTs-Ag) or non-covalently (SWCNTs-Ag-M)
b Starting concentration of TP359 used for functionalization
c First wash after centrifugation
d Second wash after centrifugation
e Third wash after centrifugation
f Fourth wash after centrifugation
g Final concentration of TP359 that was present on the functionalized nanocomposites







FSWCNTs-Ag 1000 731 48.7 12.7 0 208
SWCNTs-Ag-M 1000 818 76.2 29.7 0 76.1
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using BCA™ protein assay kit (Thermo scientific, Rock-
ford, IL, USA). Functionalization was further assessed by 
using FT-IR spectroscopy, UV–VIS spectra, atomic force 
microscopy (AFM) and transmission electron micros-
copy (TEM).
Non‑covalent functionalization of TP359 and SWCNTs‑Ag
Non covalent functionalization of SWCNTs-Ag with 
TP359 was carried out to compare with the covalent 
functionalization strategy. For this purpose, 1  mg of 
SWCNTs-Ag were mixed with 1 mg of TP359 and kept 
for stirring of the mixture for 4 h. The samples were sub-
jected to repeat centrifugation (at least four times) at 
40,000×g for 50  min and the sample was finally re-sus-
pended in 1 ml of sterile nuclease-free water and denoted 
as SWCNTs-Ag-M. Each wash after centrifugation was 
collected to measure the peptide concentration using 
BCA™ protein assay kit (Thermo scientific, Rockford, 
IL, USA). The concentration of TP359 in the covalently 
and non-covalently attached SWCNTs-Ag is presented in 
Table 3.
Characterization of TSC‑treated SWCNTs‑Ag, FSWCNTs‑Ag, 
SWCNTs‑Ag‑M and TP359 using FT‑IR, TEM
The nanocomposite formulations were characterized 
using FT-IR analysis and TEM imaging to confirm the 
presence of carboxyl group in TSC-SWCNTs-Ag and 
covalent attachment of the peptide to SWCNTs-Ag. 
In order to confirm the carboxylation of SWCNTs-Ag, 
FTIR spectra of different ratio of TSC to SWCNTs-Ag 
(such as 1:20, 1:10, 1:7.5 and 1:5) were recorded and com-
pared to only TSC and SWCNTs-Ag. The FT-IR pattern 
of FSWCNTs-Ag, SWCNTs-Ag-M, TP359 and SWC-
NTs-Ag were compared to confirm the functionalization. 
The spectra were recorded in attenuated total reflectance 
(ATR) mode using an infrared (IR) spectrophotometer 
(Nicolet 380 FT-IR; Thermo Fisher Scientific) as 64 scans 
per sample, ranging from 400 to 4000 cm−1 and a resolu-
tion of 4 cm−1. The sample chamber was purged with dry 
N2 gas.
TEM (TEM, Zeiss EM 10C 10CR, Carl Zeiss Meditec, 
Oberkochen, Germany) was used to examine the cova-
lent attachment of TP359 to SWCNTs-Ag and compared 
with TSC-SWCNTs-Ag, SWCNTs-Ag-M, TP359 and 
SWCNTs-Ag. The samples for TEM were prepared as 
described previously [12]. Briefly, the samples were soni-
cated, diluted ten times and placed on the carbon-coated 
copper grid (200 mesh) and observed by TEM.
AFM
Approximately 50  μl of SWCNTs-Ag and FSWCNTs-
Ag solution were dropped on a fresh cleaved glass slide 
and air-dried for overnight under clean bench. The dried 
samples were used to conduct atomic force microscopy 
(AFM; Asylum MF3D Conductive AFM, Santa Barbara, 
California). Air contact mode and standard silicon canti-
levers (Budget Sensors, Sofia, Bulgaria) 300 μm in length 
and 30 μm in width were used for imaging. The cantile-
ver oscillation frequency was tuned to the resonance fre-
quency of approximately 256 kHz. The set point voltage 
was adjusted for optimum image quality. Both height and 
phase information were recorded at a scan rate of 0.7 Hz, 
and in 512  ×  512 pixel format. AFM images in a large 
scanning area were processed using Asylum software 
(Asylum Research).
Ultraviolet visualization (UV–Vis)
UV–Vis was employed to ascertain the functionalization 
of the peptide TP359 on SWCNTs-Ag. SWCNTs-Ag, 
FSWCNTs-Ag and SWCNTs-Ag-M nanoparticles were 
each diluted in deionized water and their absorbance and 
spectral wavelengths were assessed using the DU 800UV/
Vis spectrophotometer (Beckman Coulter, Fullerton, 
CA).
Bacterial experiments
Salmonella enterica serovar Typhimurium (ATCC® 
13311™), Escherichia coli (ATCC® 25922™), Staphylo-
coccus aureus (ATCC® 9144™) and Streptococcus pyo-
genes (ATCC® 8135™) were purchased from American 
Type Culture Collection (ATCC, VA USA). Bacteria 
were grown at 37 °C in Luria–Bertani (LB) broth (Difco, 
Sparks, MD, USA) with continuous shaking until the 
optical density (OD) was 0.6–0.8 (at 600  nm). Bacteri-
cidal activity of SWCNTs-Ag, TP359, TSC-SWCNTs-
Ag, FSWCNTs-Ag and SWCNTs-Ag-M was investigated 
using the parameters such as minimum inhibitory con-
centrations (MIC), quantitative growth analysis and the 
Kirby-Bauer (KB) disc diffusion assay against all four 
pathogens.
Determination of minimum inhibitory concentration (MIC)
The MIC values for SWCNTs-Ag, TP359, TSC-SWC-
NTs-Ag, FSWCNTs-Ag and SWCNTs-Ag-M were 
evaluated in quadruplet wells of sterile 96-well micro-
titer plates using the broth microdilution assay as pre-
viously described broth microdilution procedure [47, 
48]. Briefly, 1 × 105 cfu/ml of the bacteria were exposed 
to doubling concentrations of the samples starting at 
0.9 μg/ml. For this purpose, the optical density of bacte-
rial culture was measured at 600 nm and the cfu/ml was 
determined using standard curve equation. One milli-
liter of media containing 1 × 109 cfu/ml of the bacteria 
were diluted tenfolds (108, 107, 106, 105) subsequently 
to obtain 1 × 105 cfu/ml of the bacteria. All plates were 
sealed lightly (with ventilation) and then incubated at 
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37 °C for 24 h. Each plate consisted of eight dilutions of 
the samples, one negative control (no sample or no bacte-
rial culture) and one positive control (only bacterial cul-
ture without samples). The concentration of the first well 
with no turbidity was considered as the MIC. The inhi-
bition of bacterial growth was determined by measuring 
absorbance at 600 nm with a TECAN Sunrise™ enzyme-
linked immunosorbent assay (ELISA) plate reader (Tecan 
US, Inc Morrisville, NC, USA). To avoid the background 
absorbance of the nanoparticles, the plates were read at 
0 h before keeping in the incubator. Then the 0 h read-
ings were subtracted from the 24 h readings to obtain the 
actual absorbance values at OD600. All experiments were 
repeated at least three times. To determine whether there 
is a synergistic or additive effect between the TP359 and 
SWCNTs-Ag in the FSWCNTs-Ag nanocomposite, we 
determined the fractional inhibitory concentration (FIC) 
test as described earlier [49]. The combined antibacterial 
effect of nanoparticles A and B (where A is TP359, B is 
SWCNTs-Ag, and AB is FSWCNTs-Ag) was calculated 
using the following formula as: 
The results were indicated as: FIC index values below 
0.5 indicate synergistic effect, above 2 indicate antagonis-
tic effects and values between 0.5 and 2.0 indicate addi-
tive effects.
Quantitative growth analysis of bacteria
Growth of all four pathogens was quantified at 24 h post-
exposure to SWCNTs-Ag, TP359, TSC-SWCNTs-Ag, 
FSWCNTs-Ag and SWCNTs-Ag-M. 1  ×  105  cfu/ml of 
the bacteria were exposed to doubling concentrations 
of the samples starting at 0.9  μg/ml. The cultures were 
incubated at 37 °C with shaking at 250 rpm for 24 h. Post 
incubation, 1  ml aliquots of bacterial culture were col-
lected, subjected to serial tenfold dilution in sterile LB 
broth, and appropriate dilution was then spread on PCA 
to determine the cfu/ml. Each sample was analyzed in 
quadruplet. The bacterial cfu/ml for each sample was 
counted and the logarithmic decrease in bacterial growth 
was expressed as log10 cfu/ml value of each sample. The 
IC50 values for plain SWCNTs-Ag and FSWCNTs-Ag 
were calculated using % inhibition on Y axis and concen-
trations on X axis.
KB assay
Based on the MIC findings, the antibacterial activity of 
TP359 and FSWCNTs-Ag at four concentrations such as 
20 (4× of MIC), 10 (2× of MIC), 5 (MIC), 2.5 (0.5× of 
MIC) μg/ml was further tested using the KB assay against 
all four pathogens as described earlier with fewer modi-














of SWCNTs-Ag [50]. Bacterial suspensions of each bac-
terial strain (105 cfu/ml) were swabbed on the surface of 
Mueller–Hinton agar plates and filter paper discs (Fisher 
Scientific, MO) containing different concentrations of 
SWCNTs-Ag, TP359 and FSWCNTs-Ag, were placed on 
the plate. A broad spectrum combination of amoxicillin 
and clavulanic acid (30 μg) was used as a positive control 
(BD, BBL™, USA). Plates were incubated at 37  °C over-
night and ‘zones of inhibition’ were observed.
In vitro cell toxicity assay
The cell toxicity to SWCNTs-Ag, TP359 and FSWCNTs-
Ag was determined using Cell Titer 96® Non-Radioac-
tive cell proliferation kit (Promega, Madison, WI). A549 
(human lung carcinoma) and J774 (murine macrophages) 
cell lines were used for the cytotoxicity assay. Cytotoxic-
ity was determined using a colorimetric assay based on 
the reduction of tetrazolium dye MTT [3-(4,5-dimeth-
ylthiazol-2yl)-2,5-diphenyltetrazolium bromide). As per 
the manufacturer’s protocol, 1 ×  104 cells/well in 100 μl 
of minimum essential medium-10 (MEM-10, Gibco, 
Life technologies, Grand Island, NY) were seeded into a 
96-well plate. After overnight incubation at 37  °C in 5 % 
CO2 humidified atmosphere, the media from the 96-well 
plate were replaced with the MEM-10 containing 20, 10, 
5 and 2.5 μg/ml of SWCNTs-Ag, TP359 and FSWCNTs-
Ag. The treated cells were further incubated at 37 °C and 
5 % CO2 for 24 and 48 h. At the end of the correspond-
ing incubation time, 15 μl of MTT dye was added into the 
each well, the plates were sealed using aluminum foil and 
was allowed to incubate again for the next 4 h. The reac-
tion was then stopped with 100  μl of stop solution. The 
absorbance of the plate was measured at 570  nm on a 
TECAN Sunrise™ enzyme-linked immunosorbent assay 
(ELISA) plate reader (Tecan US, Inc., Morrisville, NC, 
USA). Non-treated cells, in growth media, were used as 
a control.
Statistical analyses
All data are expressed as the mean  ±  standard devia-
tion (SD) unless otherwise specified. Analyses were 
performed with GraphPad Prism Version 4 software 
(GraphPad Software, Inc., La Jolla, CA). Statistical differ-
ences for MICs and cytotoxicity assay were evaluated by 
using post hoc pairwise comparison of two-way ANOVA. 
Differences were considered to be statistically significant 
when the p values were ≤0.05 or 0.01.
Additional file
Additional file 1. IC50 table, MIC graph and KB assay images against 
gram-positive and gram-negative bacteria.
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